Suboxone

buprenorphine/naloxone
Opioid Partial Agonist Indivior FDA Monitored

Safety Profile Overview

Combination opioid partial agonist for opioid use disorder treatment. Critical role in the opioid crisis response. FDA dental erosion warning added in 2022.

Generic Name
buprenorphine/naloxone
Brand Names
Suboxone
Therapeutic Class
Opioid Partial Agonist
Manufacturer
Indivior

What Pharma Signal Tracks for Suboxone

Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.

Get Suboxone Safety Data via API

One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Suboxone.

curl "https://api.pharma-signal.com/drug/safety/suboxone" \
  -H "X-API-Key: your_key"

# Returns risk score, adverse event counts,
# serious/death rates, recalls, and signals

Related Safety Intelligence

Pharma Signal provides comparative analysis across therapeutic classes. Compare Suboxone against other Opioid Partial Agonist drugs, or explore the full manufacturer portfolio for Indivior.